Vildagliptin Market Set to Witness Robust Growth as Diabetes Cases Surge Worldwide https://dataintelo.com/report/global-vildagliptin-market The Vildagliptin Market is projected to expand significantly, reaching a market value of USD 1.84 billion by 2032, up from USD 1.12 billion in 2023, growing at a CAGR of 5.7% during the forecast period. The increasing global prevalence of type 2 diabetes and rising geriatric population are key factors propelling the demand for Vildagliptin. Vildagliptin, a DPP-4 inhibitor, plays a critical role in glycemic control by enhancing the levels of incretin hormones. It is widely prescribed as a monotherapy or in combination with other antidiabetic drugs, making it a cornerstone in diabetes management across the globe.